Skip to content

An Open-label Trial to Evaluate the Safety of an Essential Oil Infused Perineal Towel

An Open-label Trial to Evaluate the Safety of an Essential Oil Infused Perineal Towel - WIPEAWAY

Status
Withdrawn
Phases
Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02509403
Acronym
WIPEAWAY
Enrollment
0
Registered
2015-07-28
Start date
2020-01-31
Completion date
2020-01-31
Last updated
2020-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Urinary Tract Infections

Keywords

Perineal hygiene, Hygiene wipes, Hygiene Towels, Safety, Essential oils, Natural Health Product

Brief summary

The purpose of this study is to assess the safety (absence of skin irritation) of a feminine hygiene product for perineal hygiene prior to undertaking a clinical effectiveness trial. The feminine hygiene towel or wipe is an anti-bacterial Natural Health Product solution.

Detailed description

The design of the trial will be open-label and uncontrolled.

Interventions

DRUGEssential oils infused Perineal Hygiene wipe

Each participant will be asked to complete a treatment period of one month's duration. At the start of the study, the participants will be asked to fill-out a baseline questionnaire and will be given a month's supply of the perineal hygiene towel with instructions about its use. At day 15, 30 and 45 follow-ups will be conducted.

Sponsors

Taiga BioActives Inc.
CollaboratorINDUSTRY
University of Alberta
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Women aged ≥18 years willing to use the perineal towels for an entire month

Exclusion criteria

* Pregnancy or within 12 months post-partum * Current vulvo-vaginitis * Known allergies to tea-tree oil

Design outcomes

Primary

MeasureTime frameDescription
Number of participants without any adverse events as a measure of safety45 DaysNumber of participants without any adverse events

Secondary

MeasureTime frameDescription
Ease of use of the perineal hygiene wipe by the participants on a daily basis30 DaysEase of use of the perineal hygiene wipe by the participants on a daily basis
Self-reported comfort score on a scale of 1 to 1030 DaysSelf-reported comfort score on a scale of 1 to 10

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026